Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer's disease

doi:10.1016/0006-8993(93)91160-T

Brain Research

Volume 632, Issues 1–2, 31 December 1993, Pages 249-259

https://doi.org/10.1016/0006-8993(93)91160-T Get rights and content

Abstract

The localization of CD44 was investigated immunohistochemically in postmortem human brain tissue of control subjects and patients with Alzheimer's disease. CD44 is a multifunctional cell surface glycoprotein in that serves as a receptor for hyaluronic acid, collagen types I and VI, and mucosal vascular addressin. In gray matter, it was found to be associated with some astrocytes of both protoplasmic and fibrous morphology. These positively stained astrocytes were most frequently observed in association with blood vessels, and had morphologies that were highly comparable to those described with the Golgi technique. Double immunostaining for CD44 and glial fibrillary acidic protein (GFAP) revealed that a significant number of these astrocytes were positive for both antigens. However, GFAP staining was mostly confined to the cell somata and proximal processes, while CD44 staining extended to a rich and extensive array of processes. Occasional CD44 positive cells of spherical morphology with a few thin varicose processes were observed. Their processes formed thick terminations on blood vessels, suggesting that these cells are a special class of astrocyte. In Alzheimer's disease brain, the number of CD44 positive astrocytes increased dramatically. These data suggest that astrocytes have very extensive branching patterns, which are reflected by CD44 staining patterns. CD44 may be an important adhesion molecule for these astrocytic processes.

References (40)

AruffoA. et al.
CD44 is the principal cell surface receptor for hyaluronate
Cell
(1990)
CarterW.G.
The cooperative role of the transformation sensitive glycoproteins, GP140 and fibronectin, in cell attachment and spreading
J. Biol. Chem.
(1982)
CarterW.G. et al.
Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells
J. Biol. Chem.
(1988)
CruzT.F. et al.
Effects of development and aging on the concentration of a human brain antigen
Neurosci. Lett.
(1985)
HaynesB.F. et al.
CD44—A molecule involved in leukocyte adherence and T-cell activation
Immunol. Today
(1989)
HughesE.N. et al.
Murine cell surface glycoproteins: characterization of a major component of 80,000 daltons asa polymorphic differentiation antigen of mesenchymal cells
J. Biol. Chem.
(1981)
McGeerP.L. et al.
Activation of the classical complement pathway in brain tissue of Alzheimer patients
Neurosci. Lett.
(1989)
MurphyG.M. et al.
Astrocytic gliosis in the amygdala in Down's syndrome and Alzheimer's disease
PotterH.
The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease
SasakiH. et al.
Morphological analysis of single astrocytes of the adult cat central nervous system visualized by HRP microinjection
Brain Res.
(1989)

TooyamaI. et al.

Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease

Brain Res.

(1990)

UnderhillC.B. et al.

Characterization and identification of the hyaluronate binding site from membranes of SV-3T3 cells

J. Biol. Chem.

(1985)

UnderhillC.B. et al.

The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity

J. Biol. Chem.

(1987)

YamadaT. et al.

Complement-activated oligodendroglia: a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d

Neurosci. Lett.

(1990)

BergE.L. et al.

Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic

Immunol. Rev.

(1989)

CajalS.R.y.

Neuroglia

CobboldS. et al.

Non-lineage, LFA-1 family and leucocyte common antigens: new and previously defined clusters

CruzT.F. et al.

Elevated levels of a glycoprotein antigen (p-80) in gray and white matter ofbrain from victims of multiple sclerosis

Neurochem. Res.

(1986)

CultyM. et al.

The hyaluronate receptor is a member of the CD44(H-CAM) family of cell surface glycoproteins

J. Cell Biol.

(1990)

DalchauR. et al.

Monoclonal antibody to a brain-granulocyte-T lymphocyte antigen probably analogous to the W3/13 antigen of the rat

Eur. J. Immunol.

(1980)

Cited by (90)

Cerebrospinal Fluid Protein Markers Indicate Neuro-Damage in SARS-CoV-2-Infected Nonhuman Primates
2023, Molecular and Cellular Proteomics
Neurologic manifestations are among the most frequently reported complications of COVID-19. However, given the paucity of tissue samples and the highly infectious nature of the etiologic agent of COVID-19, we have limited information to understand the neuropathogenesis of COVID-19. Therefore, to better understand the impact of COVID-19 on the brain, we used mass-spectrometry–based proteomics with a data-independent acquisition mode to investigate cerebrospinal fluid (CSF) proteins collected from two different nonhuman primates, Rhesus Macaque and African Green Monkeys, for the neurologic effects of the infection. These monkeys exhibited minimal to mild pulmonary pathology but moderate to severe central nervous system (CNS) pathology. Our results indicated that CSF proteome changes after infection resolution corresponded with bronchial virus abundance during early infection and revealed substantial differences between the infected nonhuman primates and their age-matched uninfected controls, suggesting these differences could reflect altered secretion of CNS factors in response to SARS-CoV-2-induced neuropathology. We also observed the infected animals exhibited highly scattered data distributions compared to their corresponding controls indicating the heterogeneity of the CSF proteome change and the host response to the viral infection. Dysregulated CSF proteins were preferentially enriched in functional pathways associated with progressive neurodegenerative disorders, hemostasis, and innate immune responses that could influence neuroinflammatory responses following COVID-19. Mapping these dysregulated proteins to the Human Brain Protein Atlas found that they tended to be enriched in brain regions that exhibit more frequent injury following COVID-19. It, therefore, appears reasonable to speculate that such CSF protein changes could serve as signatures for neurologic injury, identify important regulatory pathways in this process, and potentially reveal therapeutic targets to prevent or attenuate the development of neurologic injuries following COVID-19.
Matters of size: Roles of hyaluronan in CNS aging and disease
2021, Ageing Research Reviews
Citation Excerpt :
A histopathological analysis of brains of AD patients revealed an increase in HA content, without other GAGs in temporal lobes of patients (Jenkins and Bachelard, 1988). This observation is in line with an increased number of astrocytes expressing CD44 that displayed altered morphology in AD patients (Akiyama et al., 1993). In an accelerated senescence murine model, concomitant decreases in HA and chondroitin sulfate (CS) were observed in the brains of affected animals compared to resistant littermates (Morita and Kamada, 1993).
Involvement of extracellular matrix (ECM) components in aging and age-related neurodegeneration is not well understood. The role of hyaluronan (HA), a major extracellular matrix glycosaminoglycan, in malignancy and inflammation is gaining new understanding. In particular, the differential biological effects of high molecular weight (HMW-HA) and low molecular weight hyaluronan (LMW-HA), and the mechanism behind such differences are being uncovered. Tightly regulated in the brain, HA can have diverse effects on cellular development, growth and degeneration. In this review, we summarize the homeostasis and signaling of HA in healthy tissue, discuss its distribution and ontogeny in the central nervous system (CNS), summarize evidence for its involvement in age-related neurodegeneration and Alzheimer Disease (AD), and assess the potential of HA as a therapeutic target in the CNS.
Neuronal and microglial localization of secreted phosphoprotein 1 (osteopontin) in intact and damaged motor cortex of macaques
2019, Brain Research
Citation Excerpt :
We performed double-labeling analysis with CD44, which has been suggested by a previous study in rats to be a receptor for SPP1 in microglia (Kang et al., 2008), to investigate whether CD44 also serves as a receptor for SPP1 in primate microglia. Positive immunoreactivity for CD44 was found in small cells (10–20 µm in diameter) but not in NeuN-positive neurons in the intact M1 (data not shown); the CD44-positive small cells were presumed to be astrocytes, because a population of CD44-positive astrocytes has been reported in the human cerebral cortex (Akiyama et al., 1993; Sosunov et al., 2014). CD44 immunoreactivity dramatically increased in the lesional area compared with the intact M1 and was also localized in small cells (10 to 20 µm in diameter), which were presumed to be glial cells.
We previously reported that mRNA encoding secreted phosphoprotein 1 (SPP1), also known as osteopontin, is preferentially expressed in large neurons in layer V of the macaque motor cortex, most of which are presumed to be corticospinal tract neurons. As a first step to elucidating the cellular function of SPP1 in macaque neurons, we examined the localization of SPP1 in the primary motor cortex (M1) of the macaque by using immunohistochemistry. SPP1 immunoreactivity was found to be localized in the cell bodies of neurons, but not outside the cells, indicating that SPP1 was not secreted from these neurons. The results of electron microscope analysis and double-labeling analysis with marker proteins suggested that SPP1 was localized in the mitochondria of neurons. The distributions of SPP1 in the neurons corresponded to those of integrin αV, a putative receptor for SPP1. The distribution of SPP1 was also investigated in macaques whose M1 had been lesioned. We found that SPP1 was secreted by proliferated microglia in the lesioned area. Double-labeling analysis indicated that SPP1 immunoreactivity in the microglia was colocalized with CD44, another putative receptor for SPP1. Success rates in the small-object-retrieval task were positively correlated with SPP1 immunoreactivity in the neurons in the perilesional area. SPP1 has multiple roles in the macaque motor cortex, and it may be a key protein during recovery of hand movement after brain damage.
Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
2024, Acta Neuropathologica Communications
The Matrix Receptor CD44 Is Present in Astrocytes throughout the Human Central Nervous System and Accumulates in Hypoxia and Seizures
2024, Cells
Astrocytic CD44 Deficiency Reduces the Severity of Kainate-Induced Epilepsy
2023, Cells

View all citing articles on Scopus

View full text

Morphological diversities of CD44 positive astrocytes in the cerebral cortex of normal subjects and patients with Alzheimer's disease

Abstract

Cell

J. Biol. Chem.

J. Biol. Chem.

Neurosci. Lett.

Immunol. Today

J. Biol. Chem.

Neurosci. Lett.

Brain Res.

Brain Res.

J. Biol. Chem.

J. Biol. Chem.

Neurosci. Lett.

Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic

Immunol. Rev.

Neuroglia

Non-lineage, LFA-1 family and leucocyte common antigens: new and previously defined clusters

Elevated levels of a glycoprotein antigen (p-80) in gray and white matter ofbrain from victims of multiple sclerosis

Neurochem. Res.

The hyaluronate receptor is a member of the CD44(H-CAM) family of cell surface glycoproteins

J. Cell Biol.

Monoclonal antibody to a brain-granulocyte-T lymphocyte antigen probably analogous to the W3/13 antigen of the rat

Eur. J. Immunol.